1180P - Combination of pegilodecakin and docetaxel shows synergy in tumor rejection in immune resistant TNBC model
Autor: | Ratti, N., Shifrin, N., McCauley, S., Verma, R., Van Vlasselaer, P., Oft, M., Leveque, J. |
---|---|
Zdroj: | In Annals of Oncology October 2018 29 Supplement 8 |
Databáze: | ScienceDirect |
Externí odkaz: |